These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 3982391)
1. Suicidal destruction of cytochrome P-450 and reduction of ferrochelatase activity by 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine and its analogues in chick embryo liver cells. Marks GS; Allen DT; Johnston CT; Sutherland EP; Nakatsu K; Whitney RA Mol Pharmacol; 1985 Apr; 27(4):459-65. PubMed ID: 3982391 [TBL] [Abstract][Full Text] [Related]
2. Ferrochelatase-inhibitory activity and N-alkylprotoporphyrin formation with analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine (DDC) containing extended 4-alkyl groups: implications for the active site of ferrochelatase. McCluskey SA; Marks GS; Sutherland EP; Jacobsen N; Ortiz de Montellano PR Mol Pharmacol; 1986 Oct; 30(4):352-7. PubMed ID: 3762522 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of 3-ethoxycarbonyl-1,4-dihydro-2,4-dimethylpyridine and 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on ferrochelatase activity and heme biosynthesis in chick embryo liver cells in culture. Marks GS; Allen DT; Sutherland EP; McCluskey SA; Whitney RA Can J Physiol Pharmacol; 1986 Apr; 64(4):483-6. PubMed ID: 3730932 [TBL] [Abstract][Full Text] [Related]
4. Effects of a series of 4-alkyl analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on the major inducible cytochrome P-450 isozymes of rat liver. Riddick DS; Park SS; Gelboin HV; Marks GS Mol Pharmacol; 1989 May; 35(5):626-34. PubMed ID: 2725472 [TBL] [Abstract][Full Text] [Related]
5. Effects of 4-alkyl analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on hepatic cytochrome P-450 heme, apoproteins, and catalytic activities following in vivo administration to rats. Riddick DS; Park SS; Gelboin HV; Marks GS Mol Pharmacol; 1990 Jan; 37(1):130-6. PubMed ID: 2405248 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of griseofulvin and 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on ferrochelatase activity in chick embryo liver. Cole SP; Zelt DT; Marks GS Mol Pharmacol; 1981 May; 19(3):477-80. PubMed ID: 7266472 [No Abstract] [Full Text] [Related]
7. Inactivation of cytochrome P450 and inhibition of ferrochelatase by analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine with 4-nonyl and 4-dodecyl substituents. McCluskey SA; Riddick DS; Mackie JE; Kimmett SM; Whitney RA; Marks GS Can J Physiol Pharmacol; 1992 Aug; 70(8):1069-74. PubMed ID: 1473038 [TBL] [Abstract][Full Text] [Related]
8. Ferrochelatase-inhibitory and porphyrin-inducing properties of 3,5-diethoxycarbonyl-1, 4-dihydro-2,4,6-trimethylpyridine and its analogues in chick embryo liver cells. Cole SP; Whitney RA; Marks GS Mol Pharmacol; 1981 Sep; 20(2):395-403. PubMed ID: 7300820 [No Abstract] [Full Text] [Related]
9. Differential inhibition of hepatic ferrochelatase by regioisomers of N-butyl-, N-pentyl-, N-hexyl-, and N-isobutylprotoporphyrin IX. McCluskey SA; Marks GS; Whitney RA; Ortiz de Montellano PR Mol Pharmacol; 1988 Jul; 34(1):80-6. PubMed ID: 3393143 [TBL] [Abstract][Full Text] [Related]
10. Isolation of an N-alkylprotoporphyrin IX from chick embryo livers following the administration of 3,5-diethoxycarbonyl-1,4-dihydro-4-ethyl-2,6-dimethylpyridine. McCluskey SA; Sutherland EP; Racz WJ; Marks GS Can J Physiol Pharmacol; 1987 Jul; 65(7):1500-2. PubMed ID: 3664364 [TBL] [Abstract][Full Text] [Related]
11. Effects of porphyrin-inducing drugs on ferrochelatase activity in isolated mouse hepatocytes. Cole SP; Massey TE; Marks GS; Racz WJ Can J Physiol Pharmacol; 1981 Nov; 59(11):1155-8. PubMed ID: 7317839 [TBL] [Abstract][Full Text] [Related]
12. Patterns of porphyrin accumulation in response to xenobiotics. Parallels between results in chick embryo and rodents. Marks GS; Powles J; Lyon M; McCluskey S; Sutherland E; Zelt D Ann N Y Acad Sci; 1987; 514():113-27. PubMed ID: 3126696 [TBL] [Abstract][Full Text] [Related]
14. Isolation of regioisomers of N-alkylprotoporphyrin IX from chick embryo liver after treatment with porphyrinogenic xenobiotics. Kobus SM; Wong SG; Marks GS Can J Physiol Pharmacol; 2001 Sep; 79(9):814-21. PubMed ID: 11599783 [TBL] [Abstract][Full Text] [Related]
15. Synergistic induction of delta-aminolevulinic acid synthase activity by N-ethylprotoporphyrin IX and 3,5-diethoxycarbonyl-1,4-dihydro-2,6-dimethyl-4-isobutylpyridine . Mackie JE; Marks GS Biochem Pharmacol; 1989 Jul; 38(13):2169-73. PubMed ID: 2735955 [TBL] [Abstract][Full Text] [Related]
16. Patterns of porphyrin accumulation in response to chemicals in chick embryo liver cells. Marks GS; Follows SB; Zelt DT; Cole SP Can J Physiol Pharmacol; 1983 Jun; 61(6):546-53. PubMed ID: 6883207 [TBL] [Abstract][Full Text] [Related]
17. Irreversible binding of heme to microsomal protein during inactivation of cytochrome P450 by 4-alkyl analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine. Riddick DS; Marks GS Biochem Pharmacol; 1990 Oct; 40(8):1915-21. PubMed ID: 2242024 [TBL] [Abstract][Full Text] [Related]
18. Drug-induced porphyrin biosynthesis--XIX. Potentiation of the porphyrin-inducing effects of SKF 525-A in the chick embryo liver by 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine, an antihibitor of ferrochelatase. Cole SP; Vavasour EJ; Marks GS Biochem Pharmacol; 1979 Dec; 28(24):0533-8. PubMed ID: 533555 [No Abstract] [Full Text] [Related]
19. Cytochrome P450 and its interactions with the heme biosynthetic pathway. De Matteis F; Marks GS Can J Physiol Pharmacol; 1996 Jan; 74(1):1-8. PubMed ID: 8963944 [TBL] [Abstract][Full Text] [Related]
20. Porphyrinogenic activity and ferrochelatase-inhibitory activity of sydnones in chick embryo liver cells. Sutherland EP; Marks GS; Grab LA; Ortiz de Montellano PR FEBS Lett; 1986 Mar; 197(1-2):17-20. PubMed ID: 3949013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]